Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about ESALY

Recent news which mentions ESALY

< Previous 1 2 3 4 Next >
Merck-Eisai Partnered Two Keytruda/Lenvima Combo Trials Flunk In Certain Types Of Lung Cancer
Tickers ESALF ESALY MRK
Tags ESALF MRK Market News
From Benzinga
Merck/Eisai's Cancer Combo Therapy Ambition Dashed Once Again, Companies Throw Towel On Head & Neck Trial
Tickers ESALF ESALY MRK
Tags General News Briefs
From Benzinga
Biogen's Just Made Its Biggest Acquisition. Here's What You Need to Know.
Tickers BIIB ESALY RETA
Tags Market News Recent Press Releases RETA
From Motley Fool
Expanded Medicare Coverage For Biogen-Eisai's Leqembi Signals a Turning Point in Alzheimer's Treatment: Analysts
Tickers BIIB ESALF ESALY
Tags ESALF Trading Ideas Analyst Color
From Benzinga
Senator Bernie Sanders Puts Brakes on Health Agency Nominees Until Drug Pricing Issue is Addressed
Tickers BIIB ESALY
Tags Benzinga Government ESALY
From Benzinga
FTC Sues To Block Microsoft-Activision Blizzard Deal, Netflix's First Sports Streaming Debut, EU Mulls Antitrust Case Against Google's Ad-Tech Business: Today's Top Stories
Tickers AAPL ATVI BEP BIIB
Tags MSFT DUK General
From Benzinga
Alzheimer's Drug Leqembi Faces Hurdles in Europe: Concerns Over Health Risks and Healthcare Resources
Tickers BIIB ESALF ESALY
Tags General News Briefs
From Benzinga
Prospects for Full Approval of Eisai and Biogen's Leqembi Shine Brighter after FDA Committee Vote
Tickers BIIB ESALF ESALY
Tags FDA General News
From Benzinga
Nasdaq, S&amp;P 500 Futures Signal Strong Start To Week On Hopes Of Fed Pause: Why This Analyst Is Pricing In A 20% Gain From Bear Market Low
Tickers BIIB ESALY ILMN KDNY
Tags Markets SPY News
From Benzinga
Bernie Sanders Takes on High Costs of Alzheimer's Treatment Leqembi, Calls Price Tag 'Unconscionable'
Tickers BIIB ESALF ESALY
Tags Market News Biotech Alzheimer’s
From Benzinga
Amazon Considers Launching Ad-Supported Prime Video Tier, Google & Microsoft Face Backlash For Ad Inclusion In AI Trials, Airbus Records One-Third Jump In May Deliveries: Today's Top Stories
Tickers AMZN BLK DIS EADSY
Tags TOSBF SPY Markets
From Benzinga
FDA Signals Support for Eisai-Biogen Alzheimer's Drug Data Confirms Benefits For Complete Approval
Tickers BIIB ESALF ESALY
Tags ESALY Benzinga Briefs
From Benzinga
Medtronic, Merck, Williams Companies And More: CNBC's 'Final Trades'
Tickers ESALY IEF MDT MRK
Tags Top Stories MDT WMB
From Benzinga
After Back To Back Failure For Keytruda Plus Lenvima, Merck Touts Durable Clinical Benefit For The Combo In Advanced Kidney Cancer
Tickers ESALY MRK PFE
Tags Health Care News Large Cap
From Benzinga
Analysts Say Eli Lilly's Donanemab In Alzheimer's Is Encouraging, Outline Potential Implications For Biogen
Tickers BIIB ESALF ESALY LLY
Tags LLY Expert Ideas Health Care
From Benzinga
Will US Medicare Fully Cover Alzheimer's Drugs? Eli Lilly Thinks Yes!
Tickers BIIB ESALF ESALY LLY
Tags ESALF Government Market News
From Benzinga
Merck, Eisai Shelve Keytruda Plus Lenvima Combo Trial In Skin Cancer Setting, Disappoints In Certain Type Of Colorectal Cancer
Tickers ESALF ESALY MRK
Tags ESALF Market News Biotech
From Benzinga
Tesla Manufactured 4,000 Model Ys In One Week, UBS Prepping For Massive Layoffs, McDonald's Temporary Shuttering Of US Offices: Today's Top Stories
Tickers ATVI BIIB BOXD CS
Tags Legal Market News Biotech
From Benzinga
National Institute on Aging Aims Building $300M Alzheimer's Research Database
Tickers BIIB ESALF ESALY
Tags Health Care ESALY Benzinga
From Benzinga
Eisai-Biogen Highlights Additional Data From Recently Approved Alzheimer's Drug
Tickers BIIB ESALF ESALY
Tags Health Care Market News Biotech
From Benzinga
7 Healthcare Stocks to Buy for Long-Term Growth and Stability
Tickers BIIB ESALY HRMY INCY
Tags LLY BIIB MRK
From InvestorPlace
Alzheimer's Association Launches Grassroots Level Lobbying For Medicare Coverage Of Alzheimer's Treatments
Tickers BIIB ESALF ESALY LLY
Tags Market News Biotech Alzheimer’s
From Benzinga
Analyst Says Biogen-Eisai's Alzheimer's Treatment Leqembi Coverage Enables Access To Over $2.5B Market Opportunity
Tickers BIIB ESALF ESALY
Tags Health Care Expert Ideas News
From Benzinga
Eisai-Biogen Seek Complete FDA Approval For Its Second Alzheimer's Treatment
Tickers BIIB ESALF ESALY
Tags Large Cap News Briefs
From Benzinga
Why Anavex Life Sciences Stock Bolted Higher in January
Tickers AVXL BIIB ESALY
Tags Recent Press Releases Market News ESALY
From Motley Fool
February PDUFA Catalysts Biotech Investors Must Know: Sanofi's Bleeding Disorder Drug, Regeneron's Twin Eylea Label Expansions, 3 Delayed Approvals And More
Tickers APLS BIIB CYTK EBS
Tags RETA SGEN TVTX
From Benzinga
Is Biogen Stock a No-Brainer Buy After Eli Lilly's Alzheimer's Disease Setback?
Tickers BIIB ESALY LLY
Tags BIIB LLY ESALY
From Motley Fool
Why Biogen's Stock Isn't Soaring Since Its Alzheimer's Drug Got Approval
Tickers BIIB ESALY
Tags Recent Press Releases Market News BIIB
From Motley Fool
This Monumental Breakthrough Could Turn the World Upside Down -- and Make Some Investors Filthy Rich
Tickers ABBV BIIB ESALY GOOG
Tags ESALY ABBV BIIB
From Motley Fool
Should You Buy Biogen Stock After Its Latest Alzheimer's Disease Drug Approval?
Tickers BIIB ESALY
Tags Recent Press Releases Market News ESALY
From Motley Fool
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.